{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:04:54Z","timestamp":1744171494585,"version":"3.40.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-025-01914-3","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:37:49Z","timestamp":1744083469000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the clinical pharmacist\u2019s effect on achieving treatment goals in patients with hypothyroidism: a randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6093-0849","authenticated-orcid":false,"given":"Yunus Emre","family":"Ayhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-9957","authenticated-orcid":false,"given":"Muhammed Yunus","family":"Bektay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0075-6313","authenticated-orcid":false,"given":"Dilek","family":"Gogas Yavuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-3235","authenticated-orcid":false,"given":"Mesut","family":"Sancar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"1914_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/BMB\/LDR030","volume":"99","author":"MPJ Vanderpump","year":"2011","unstructured":"Vanderpump MPJ. The epidemiology of thyroid disease. Br Med Bull. 2011;99:39\u201351. https:\/\/doi.org\/10.1093\/BMB\/LDR030","journal-title":"Br Med Bull"},{"issue":"17","key":"1914_CR2","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0140-6736","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP, Hypothyroidism. Lancet. 2017;390(17):1550\u201362. https:\/\/doi.org\/10.1016\/S0140-6736","journal-title":"Lancet"},{"key":"1914_CR3","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1089\/THY.2014.0028","volume":"24","author":"J Jonklaas","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi FS, et al. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24:1670. https:\/\/doi.org\/10.1089\/THY.2014.0028","journal-title":"Thyroid"},{"key":"1914_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1210\/JC.2004-1306","volume":"90","author":"F Santini","year":"2005","unstructured":"Santini F, Pinchera A, Marsili A, Ceccarini G, Castagna MG, Valeriano R, et al. Lean body mass is a major determinant of Levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab. 2005;90:124\u20137. https:\/\/doi.org\/10.1210\/JC.2004-1306","journal-title":"J Clin Endocrinol Metab"},{"key":"1914_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/NRENDO.2013.258","volume":"10","author":"WM Wiersinga","year":"2014","unstructured":"Wiersinga WM. Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism. Nat Rev Endocrinol. 2014;10:164\u201374. https:\/\/doi.org\/10.1038\/NRENDO.2013.258","journal-title":"Nat Rev Endocrinol"},{"key":"1914_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5530\/jyp.2018.10.70","volume":"10","author":"K Iyer","year":"2018","unstructured":"Iyer K, Dilipkumar N, Vasaya S, Pawar S, Diwan A. Comparison of drug related problems associated with use of narrow therapeutic index drugs and other drugs in hospitalized patients. J Young Pharmacists. 2018;10:318\u201321. https:\/\/doi.org\/10.5530\/jyp.2018.10.70","journal-title":"J Young Pharmacists"},{"key":"1914_CR7","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1691\/ph.2014.3848","volume":"69","author":"SG Schorr","year":"2014","unstructured":"Schorr SG, Eickhoff C, Feldt S, Hohmann C, Schulz M, Schulz M. Exploring the potential impact of hospital ward-based pharmacy interns on drug safety. Pharmazie. 2014;69:316\u201320. https:\/\/doi.org\/10.1691\/ph.2014.3848","journal-title":"Pharmazie"},{"key":"1914_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/2042018818771433","volume":"9","author":"GM Rdzak","year":"2018","unstructured":"Rdzak GM, Whitman LM, Inzucchi SE. Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting. Therapeutic Adv Endocrinol Metabolism. 2018;9:217\u201322. https:\/\/doi.org\/10.1177\/2042018818771433","journal-title":"Therapeutic Adv Endocrinol Metabolism"},{"issue":"4","key":"1914_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/PHAR.1578","volume":"35","author":"C Langebrake","year":"2015","unstructured":"Langebrake C, Ihbe-Heffinger A, Leichenberg K, Kaden S, Kunkel M, Lueb M, et al. Nationwide evaluation of day-to-day clinical pharmacists\u2019 interventions in German hospitals. Pharmacotherapy. 2015;35(4):370\u20139. https:\/\/doi.org\/10.1002\/PHAR.1578","journal-title":"Pharmacotherapy"},{"key":"1914_CR10","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1089\/THY.2007.0060","volume":"17","author":"J John-Kalarickal","year":"2007","unstructured":"John-Kalarickal J, Pearlman G, Carlson HE. New medications which decrease Levothyroxine absorption. Thyroid: Official J Am Thyroid Association. 2007;17:763\u20135. https:\/\/doi.org\/10.1089\/THY.2007.0060","journal-title":"Thyroid: Official J Am Thyroid Association"},{"key":"1914_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1089\/THY.2010.0296","volume":"21","author":"I Zamfirescu","year":"2011","unstructured":"Zamfirescu I, Carlson HE. Absorption of Levothyroxine when coadministered with various calcium formulations. Thyroid: Official J Am Thyroid Association. 2011;21:483\u20136. https:\/\/doi.org\/10.1089\/THY.2010.0296","journal-title":"Thyroid: Official J Am Thyroid Association"},{"key":"1914_CR12","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1001\/JAMA.283.21.2822","volume":"283","author":"N Singh","year":"2000","unstructured":"Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of Levothyroxine. JAMA. 2000;283:2822\u20135. https:\/\/doi.org\/10.1001\/JAMA.283.21.2822","journal-title":"JAMA"},{"key":"1914_CR13","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/S11606-020-06403-Y","volume":"36","author":"Y Guzman-Prado","year":"2021","unstructured":"Guzman-Prado Y, Vita R, Samson O. Concomitant use of Levothyroxine and proton pump inhibitors in patients with primary hypothyroidism: a systematic review. J Gen Intern Med. 2021;36:1726\u201333. https:\/\/doi.org\/10.1007\/S11606-020-06403-Y","journal-title":"J Gen Intern Med"},{"key":"1914_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cen.12559","volume":"82","author":"SA Irving","year":"2015","unstructured":"Irving SA, Vadiveloo T, Leese GP. Drugs that interact with levothyroxine: an observational study from the thyroid epidemiology, audit and research study (TEARS). Clin Endocrinol. 2015;82:136\u201341. https:\/\/doi.org\/10.1111\/cen.12559","journal-title":"Clin Endocrinol"},{"key":"1914_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/FENDO.2017.00215","volume":"8","author":"DG Yavuz","year":"2017","unstructured":"Yavuz DG, Yazici D, Keskin L, Atmaca A, Sancak S, Sara\u00e7 F, et al. Out-of-Reference range Thyroid-Stimulating hormone levels in Levothyroxine-Treated primary hypothyroid patients: A multicenter observational study. Front Endocrinol. 2017;8:215. https:\/\/doi.org\/10.3389\/FENDO.2017.00215","journal-title":"Front Endocrinol"},{"key":"1914_CR16","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/BMJ.C332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:698\u2013702. https:\/\/doi.org\/10.1136\/BMJ.C332","journal-title":"BMJ"},{"key":"1914_CR17","unstructured":"Interactions - UpToDate\u00ae LexidrugTM. https:\/\/8dd63de3f8d7136be0d2b72d5f9d904ed6e885a8.vetisonline.com\/lco\/action\/interact (accessed 11 Dec 2024)."},{"key":"1914_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","volume":"24","author":"DE Morisky","year":"1986","unstructured":"Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67\u201374. https:\/\/doi.org\/10.1097\/00005650-198601000-00007","journal-title":"Med Care"},{"key":"1914_CR19","doi-asserted-by":"publisher","unstructured":"Van Welie S, Wijma L, Beerden T, Van Doormaal J, Taxis K. Effect of warning symbols in combination with education on the frequency of erroneously crushing medication in nursing homes: an uncontrolled before and after study. BMJ Open. 2016;e012286. https:\/\/doi.org\/10.1136\/BMJOPEN-2016-012286. 6.","DOI":"10.1136\/BMJOPEN-2016-012286"},{"key":"1914_CR20","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1210\/JC.2008-1696","volume":"94","author":"LL Somwaru","year":"2009","unstructured":"Somwaru LL, Arnold AM, Joshi N, Fried LP, Cappola AR. High frequency of and factors associated with thyroid hormone over-Replacement and Under-Replacement in men and women aged 65 and over. J Clin Endocrinol Metab. 2009;94:1342\u20135. https:\/\/doi.org\/10.1210\/JC.2008-1696","journal-title":"J Clin Endocrinol Metab"},{"key":"1914_CR21","first-page":"107","volume":"43","author":"JV Parle","year":"1993","unstructured":"Parle JV, Franklyn JA, Cross KW, Jones SR, Sheppard MC. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract. 1993;43:107\u20139.","journal-title":"Br J Gen Pract"},{"key":"1914_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/J.PHCLIN.2021.05.002","volume":"56","author":"AM Joy","year":"2021","unstructured":"Joy AM, UP N, Chand S, Shetty KJ, George SM, Chacko CS, et al. Role of clinical pharmacist in the medication adherence behaviour of cancer patients: an interventional study. Le Pharmacien Hospitalier Et Clinicien. 2021;56:291\u20137. https:\/\/doi.org\/10.1016\/J.PHCLIN.2021.05.002","journal-title":"Le Pharmacien Hospitalier Et Clinicien"},{"key":"1914_CR23","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/08971900221111139","volume":"36","author":"SA Parakkal","year":"2022","unstructured":"Parakkal SA, Hakeem FA, Madathil H, Alabidi RA, Alfaifi AY, Nemr HS, et al. Pharmacist-Mediated Thyroid-Stimulating hormone (TSH) test guideline monitoring Program- outcomes of a retrospective study in patients on Levothyroxine. J Pharm Pract. 2022;36:1336\u201342. https:\/\/doi.org\/10.1177\/08971900221111139","journal-title":"J Pharm Pract"},{"key":"1914_CR24","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2147\/PPA.S110167","volume":"10","author":"C Xin","year":"2016","unstructured":"Xin C, Xia Z, Jiang C, Lin M, Li G. The impact of pharmacist-managed clinic on medication adherence and health-related quality of life in patients with COPD: a randomized controlled study. Patient Prefer Adherence. 2016;10:1197. https:\/\/doi.org\/10.2147\/PPA.S110167","journal-title":"Patient Prefer Adherence"},{"key":"1914_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/0975-1483.96623","volume":"4","author":"KV Ramanath","year":"2012","unstructured":"Ramanath KV, Balaji DBSS, Nagakishore CH, Mahesh Kumar S, Bhanuprakash M. A study on impact of clinical pharmacist interventions on medication adherence and quality of life in rural hypertensive patients. J Young Pharmacists. 2012;4:95\u2013100. https:\/\/doi.org\/10.4103\/0975-1483.96623","journal-title":"J Young Pharmacists"},{"key":"1914_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/JCN.0000000000000511","volume":"33","author":"H Al-Noumani","year":"2018","unstructured":"Al-Noumani H, Wu JR, Barksdale D, Knafl G, Alkhasawneh E, Sherwood G. Health beliefs and medication adherence in Omanis with hypertension. J Cardiovasc Nurs. 2018;33:518\u201326. https:\/\/doi.org\/10.1097\/JCN.0000000000000511","journal-title":"J Cardiovasc Nurs"},{"key":"1914_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/0897190017707120","volume":"31","author":"CM Vinluan","year":"2018","unstructured":"Vinluan CM, Jabalie MM, Navarrete JP, Padilla ME. Evaluating the types of pharmacy student interventions made during an interprofessional 6-Week adult internal medicine rotation. J Pharm Pract. 2018;31:298\u2013303. https:\/\/doi.org\/10.1177\/0897190017707120","journal-title":"J Pharm Pract"},{"key":"1914_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharma.2012.02.004","volume":"70","author":"AH Al-Hajje","year":"2012","unstructured":"Al-Hajje AH, Atoui F, Awada S, Rachidi S, Zein S, Salameh P. Drug-related problems identified by clinical pharmacist\u2019s students and pharmacist\u2019s interventions. Ann Pharm Fr. 2012;70:169\u201376. https:\/\/doi.org\/10.1016\/j.pharma.2012.02.004","journal-title":"Ann Pharm Fr"},{"key":"1914_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00228-004-0830-4","volume":"60","author":"HS Blix","year":"2004","unstructured":"Blix HS, Viktil KK, Reikvam \u00c5, Moger TA, Hjemaas BJ, Pretsch P, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60:651\u20138. https:\/\/doi.org\/10.1007\/s00228-004-0830-4","journal-title":"Eur J Clin Pharmacol"},{"key":"1914_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.33483\/jfpau.1235458","volume":"47","author":"YE Ayhan","year":"2023","unstructured":"Ayhan YE, Sancar M. Interventions in internal medicine wards with scope of clinical pharmacy residency program: a retrospective study. Ankara Univ Fac Pharm J. 2023;47:557\u201366. https:\/\/doi.org\/10.33483\/jfpau.1235458","journal-title":"Ankara Univ Fac Pharm J"},{"key":"1914_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/AJHP\/54.4.397","volume":"54","author":"ND Barber","year":"1997","unstructured":"Barber ND, Batty R, Ridout DA. Predicting the rate of physician-accepted interventions by hospital pharmacists in the united Kingdom. Am J health-system Pharmacy: AJHP: Official J Am Soc Health-System Pharmacists. 1997;54:397\u2013405. https:\/\/doi.org\/10.1093\/AJHP\/54.4.397","journal-title":"Am J health-system Pharmacy: AJHP: Official J Am Soc Health-System Pharmacists"},{"key":"1914_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11096-015-0213-1","volume":"38","author":"R Lenssen","year":"2016","unstructured":"Lenssen R, Heidenreich A, Schulz JB, Trautwein C, Fitzner C, Jaehde U, et al. Analysis of drug-related problems in three departments of a German university hospital. Int J Clin Pharm. 2016;38:119\u201326. https:\/\/doi.org\/10.1007\/s11096-015-0213-1","journal-title":"Int J Clin Pharm"},{"key":"1914_CR33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11096-017-0585-5","volume":"40","author":"N Abunahlah","year":"2018","unstructured":"Abunahlah N, Elawaisi A, Velibeyoglu FM, Sancar M. Drug related problems identified by clinical pharmacist at the internal medicine ward in Turkey. Int J Clin Pharm. 2018;40:360\u20137. https:\/\/doi.org\/10.1007\/s11096-017-0585-5","journal-title":"Int J Clin Pharm"},{"key":"1914_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/THY.2007.0222","volume":"18","author":"S Benvenga","year":"2008","unstructured":"Benvenga S, Bartolone L, Pappalardo MA, Russo A, Lapa D, Giorgianni G, et al. Altered intestinal absorption of L-thyroxine caused by coffee. Thyroid: Official J Am Thyroid Association. 2008;18:293\u2013301. https:\/\/doi.org\/10.1089\/THY.2007.0222","journal-title":"Thyroid: Official J Am Thyroid Association"},{"key":"1914_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/PH14030206","volume":"14","author":"A Wiesner","year":"2021","unstructured":"Wiesner A, Gajewska D, Pa\u015bko P. Levothyroxine interactions with food and dietary Supplements-A systematic review. Pharmaceuticals. 2021;14:206. https:\/\/doi.org\/10.3390\/PH14030206","journal-title":"Pharmaceuticals"},{"key":"1914_CR36","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/S40261-015-0271-0\/METRICS","volume":"35","author":"G Trifir\u00f2","year":"2015","unstructured":"Trifir\u00f2 G, Parrino F, Sultana J, Giorgianni F, Ferrajolo C, Bianchini E, et al. Drug interactions with Levothyroxine therapy in patients with hypothyroidism: observational study in general practice. Clin Drug Investig. 2015;35:187\u201395. https:\/\/doi.org\/10.1007\/S40261-015-0271-0\/METRICS","journal-title":"Clin Drug Investig"},{"key":"1914_CR37","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMOA043903","volume":"354","author":"M Centanni","year":"2006","unstructured":"Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Fave GD, et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med. 2006;354:1787\u201395. https:\/\/doi.org\/10.1056\/NEJMOA043903","journal-title":"N Engl J Med"},{"key":"1914_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4158\/EP.13.4.345","volume":"13","author":"I Sachmechi","year":"2007","unstructured":"Sachmechi I, Reich DM, Aninyei M, Wibowo F, Gupta G, Kim PJ. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with Levothyroxine for hypothyroidism. Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists. 2007;13:345\u20139. https:\/\/doi.org\/10.4158\/EP.13.4.345","journal-title":"Endocr Practice: Official J Am Coll Endocrinol Am Association Clin Endocrinologists"},{"key":"1914_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/J.EJPB.2008.10.008","volume":"72","author":"D Pabla","year":"2009","unstructured":"Pabla D, Akhlaghi F, Zia H. A comparative pH-dissolution profile study of selected commercial Levothyroxine products using inductively coupled plasma mass spectrometry. Eur J Pharm Biopharmaceutics: Official J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik E V. 2009;72:105\u201310. https:\/\/doi.org\/10.1016\/J.EJPB.2008.10.008","journal-title":"Eur J Pharm Biopharmaceutics: Official J Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik E V"},{"key":"1914_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/S-2006-924980","volume":"38","author":"JW Dietrich","year":"2006","unstructured":"Dietrich JW, Gieselbrecht K, Holl RW, Boehm BO. Absorption kinetics of Levothyroxine is not altered by proton-pump inhibitor therapy. Hormone Metabolic Res = Hormon- Und Stoffwechselforschung = Horm Et Metab. 2006;38:57\u20139. https:\/\/doi.org\/10.1055\/S-2006-924980","journal-title":"Hormone Metabolic Res = Hormon- Und Stoffwechselforschung = Horm Et Metab"},{"key":"1914_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/THY.2007.0381","volume":"18","author":"S Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan S, Braverman LE, Levin RM, Magnani B, Pearce EN. The effect of famotidine, Esomeprazole, and Ezetimibe on Levothyroxine absorption. Thyroid. 2008;18:493\u20138. https:\/\/doi.org\/10.1089\/THY.2007.0381","journal-title":"Thyroid"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-025-01914-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-025-01914-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:37:52Z","timestamp":1744083472000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-025-01914-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1186\/s12902-025-01914-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"9 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received ethical approval from the Clinical Research Ethics Committee of Marmara University Faculty of Medicine (Decision No: 09.2022.425), and written informed consent was obtained from all participants. All procedures adhered to the ethical standards of the University of Siena and the principles of the 1964 Helsinki Declaration and its later amendments. This study protocol has been retrospectively registered at ClinicalTrials.gov (NCT06408909) at 06\/05\/2024.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}